* Pulmatrix Inc PULM.OQ PULM.O is expected to show a fall in
quarterly revenue when it reports results on August 5
(estimated).
* Refinitiv's mean analyst estimate for Pulmatrix Inc is for a
loss of 10 cents per share. For the same quarter last year, the
company reported a loss of 5 cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in the
last three months.
* Wall Street's median 12-month price target for Pulmatrix Inc
is $5, about 83.2% above its last closing price of $0.84.
* Previous quarterly performance (using preferred earnings
measure in US dollars).
QUARTER STARMINE REFINITIV ACTUAL BEAT, SURPRI
ENDING SMARTESTIM IBES MET, SE %
ATE® ESTIMATE MISSED
Mar. 31 2021 -0.10 -0.10 -0.09 Beat 10
Dec. 31 2020 -0.19 -0.05 Beat 73.7
Sep. 30 2020 -0.22 -0.22 -0.04 Beat 81.8
Jun. 30 2020 -0.38 -0.38 -0.05 Beat 86.8
Mar. -0.22 -0.22 -0.23 Missed -4.5
31 2020
Dec. 31 2019 -0.27 -0.16 Beat 40.7
Sep. 30 2019 -0.34 -0.34 -0.18 Beat 47.1
Jun. 30 2019 -0.39 -0.39 -0.41 Missed -5.1
This summary was machine generated August 3 at 13:23 GMT. All
figures in US dollars unless otherwise stated